Skip to main navigation menu Skip to main content Skip to site footer

Original article

Vol. 140 No. 2728 (2010)

Patients with influenza A/H1N1v-associated pneumonia: the perspective of a tertiary care hospital in Switzerland

  • B Bertisch
  • P Vernazza
  • K Boggian
DOI
https://doi.org/10.4414/smw.2010.13069
Cite this as:
Swiss Med Wkly. 2010;140:w13069
Published
05.07.2010

Abstract

During the 2009/10 influenza A/H1N1v pandemic in Switzerland, we followed the disease course of of all 15 patients with A/H1N1v-associated pneumonia whom we identified at our tertiary care hospital. Eight of the patients had previously known risk factors for A/H1N1v disease compliction, according to WHO criteria. All patients showed signs and/or symptoms of complicated influenza. 14 patients had to be hospitalised with a median hospital stay of 8–9 days; 6 were admitted to intensive care, of whom 3 required intubation. According to WHO recommendations, oseltamivir should be started as early as possible, both in patients with risk factors for severe disease and in any patient presenting with symptoms of progressive disease. If treated early according to these guidelines, half of our patients might not have developed pneumonia at all. In the remaining patients without preexisting risk factors, the clinical course of pneumonia might have been milder. It is questionable whether the delayed oseltamivir treatment still influenced the clinical outcome, but no patient died; the two patients who were discharged with new home oxygen therapy apparatus had presented massive preexisting morbidities.

References

  1. Swiss Federal Office of Public Health. http://www.bag.admin.ch/influenza/06411/index.html?lang=de
  2. WHO. http://www.who.int/csr/disease/swineflu/notes/h1n1_clinical_features_20091016/en/index.html
  3. Gilsdorf A, Poggensee G, on behalf of the working group pandemic influenza A(H1N1)v. Influenza A(H1N1)v in Germany: the first 10 000 cases. Euro Surveill. 2009;14(34):pii=19318.
  4. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360:2605–15.
  5. ECDC. http://ecdc.europa.eu/en/activities/surveillance/EISN/Newsletter/100129_EISN_Weekly_Influenza_Surveillance_Overview.pdf
  6. Gomez-Gomez A, Magana-Aquino M, Garcia-Sepulveda CA, Ochoa-Perez AR, Falcon-Escobedo R, Comas-Garcia A, et al. Severe Pneumonia Associated with Pandemic (H1N1) 2009 Outbreak, San Luis Potosi, Mexico. Emerg Infect Dis. 2010;16(1):27–32.
  7. Louie J, Winter K, Harriman K, Vugia D, Glaser C, Matyas B et al. Hospitalized patients with novel influenza a (H1N1) infection-California, April-May,2009. MMWR. 2009;58:536–41.
  8. Napolitano LM, Park PK, Sihler KC, Papadimos MD, Chenoweth C, Cinti S. Intensive-care patients with severe novel influenza A(H1N1) virus infection – Michigan, June 2009. MMWR. 2009;58(27):749–52.
  9. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit ST, Louie J, et al. Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009. N Engl J Med. 2009;361:1935–44.
  10. Kumar A, Zarychanski R, Pinto R, Cook DJ, Marshall J, Lacroix J, et al (for the Canadian Critical Care Trials Group H1N1 Collaborative). Critically Ill Patients with 2009 Influenza A(H1N1) Infection in Canada. JAMA. 2009;302(17):1872–9.
  11. Rello J, Rodriguez A, Ibanez P, Socias L, Cebrian J, Marques A. Intensive care adult patients with severe respiratory failure caused by influenza A /H1N1)v in Spain. Crit Care. 2009;13(5):R148.
  12. Webb SAR, Pettilä V, Seppelt I, Bellomo R, Bailey M. Cooper DJ. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361:1925–34.
  13. Cullen G, Martin J, O’Donnell J, Boland M, Canny M, Keane E, et al. Surveillance of the first 205 confirmed hospitalised cases of pandemic H1N1 influenza in Ireland, 28 April – 3 October 2009. Euro Surveill. 2009;14(44):ppi=19389.
  14. Yeung JHY, Bailey M, Perkins GD, Gao Smith F. Presentation and management of critically ill patients with influenza A(H1N1): a UK perspective. Critical Care 2009;13:426.
  15. Rothberg MB, Haessler SD. Complications of seasonal and pandemic influenza. Crit Care Med 2010;38(3):(Suppl.)
  16. Louie J, Jean C, Chen TH, Park S, Ueki R, Harper T, et al. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1) – United States, May-August 2009. MMWR. 2009/58(38):1071–4.
  17. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, Hernandez M, Quinones-Falconi F, Bautista E, et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med. 2009;361:680–9.
  18. Davies A, Jones D, Bailey M., Beca J, Bellomo R, Blackwell N, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;302(17):1888–95.
  19. WHO: Clinical management of human infection with pandemic (H1N1) 2009: revised guidance; November 2009. http://www.who.int/csr/resources/publications/swineflu/clinical_management_h1n1.pdf
  20. Uyeki T. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1). N Engl J Med. 2009;361:e110.
  21. Dominguez-Cherit G, Lapinsky SD, Macias AE, Pinto R, Espinosa-Perez, L. Critically ill patients with 2009 influenza A/H1N1) in Mexico. JAMA. 1009;302(17):1880–7.
  22. Kaiser L, Wat C, Mills T, Mahoney P, Ward P, Hayden F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch Intern Med. 2003;163:1667–72.
  23. Freemantle N, Calvert M. What can we learn from observational studies of oseltamivir to treat influenza in healthy adults? BMJ. 2009;339:b5248.
  24. Doshi P. Neuraminidase inhibitors: the story behind the Cochrane review. BMJ. 2009;339:b5164.
  25. McGeer A, Green KA, Plevneshi A, Shigayeva A, Siddiqi N, Raboud J, Low DE. Antiviral therapy and outcomes of influenza requiring hospitalisation in Ontario, Canada. CID 2007;45:1568–75.
  26. Toovey S. Avex Avian Influenza Expert Group. First results from an avian influenza case registry. Oral presentation at Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) 2009. Abstract V-533, 9/13/2009.
  27. Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, Meduri GU. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med. 2010;36:33–41.
  28. Kono M, Tatsumi K, Saibara T, Nakamura A, Tanabe N, Takiguchi Y, Kuriyama T. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest. 2007;131:1387–92.
  29. Ajlan AM, Quiney B, Nicolaou S, Müller NL. Swine-origin influenza A (H1N1) viral findings: radiographic and CT findings. AJR. 2009;193:1–6.
  30. Swiss Federal Office of Public Health. Hospitalisation reasons and death of confirmed influenza A/H1N1v cases in Switzerland from week 17, 2009, to week 22, 2010. Personal communication (March 18th and June 7th, 2010).